Drug Trial Radar · NCT06745557
Phase III Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Last checked: Nov 19, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Dec 13, 2024
Primary completion
Jun 30, 2027
Study completion Jun 30, 2029
Sponsor
- Lead sponsor
- CUTISS AGIndustry
- Sponsor type
- Industry
- Collaborators
- RCTs
- First posted
- Dec 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multicentre phase III clinical trial will target adults and adolescents of 12 years and older with severe burns to confirm the efficacy and functionality of denovoSkin™ in achieving wound closure and reducing scarring in patients with deep partial and full-thickness burns as compared to split-thickness skin.
Conditions
- Burns
Interventions
denovoSkin(TM)Biological
Transplantation of autologous dermo-epidermal skin substitute denovoSkin(TM) to the experimental area
STSGOther
Transplantation of autologous split-thickness skin to the control area
Primary outcomes
What the sponsor says the trial is designed to measure.
- A composite endpoint whereby success is defined by meeting both of the following criteria: - Wound closure - Scar quality (POSAS v2.0)Time frame: 6 months post grafting
Locations
19 sites in 9 countries. Site status is shown where the registry gives one.
CHU de Liège Département de pharmacie hospitalière - Secteur Essais cliniques
Liège, Belgium · Recruiting
Hopital Edouard Herriot Centre des Brûlés de Lyon
Lyon, France · Recruiting
Pharmacie Hôpital Conception
Marseille, France · Recruiting
Centre Hospitalier Universitaire de Montpellier
Montpellier, France · Recruiting
BG Klinikum Unfallkrankenhaus Berlin
Berlin, Germany · Recruiting
BG Klinikum Bergmannstrost Halle
Halle, Germany · Recruiting
Medizinische Hochschule Hannover
Hanover, Germany · Not yet recruiting
BG-Unfallklinik Murnau
Murnau am Staffelsee, Germany · Recruiting
Santobono-Pausilipon
Naples, Italy · Recruiting
Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli
Naples, Italy · Recruiting
AOU Padova
Padova, Italy · Not yet recruiting
Rode Kruis Ziekenhuis
Beverwijk, Netherlands · Recruiting
Maasstad Hospital Dep. Burn Wound Centre
Rotterdam, Netherlands · Recruiting
Samodzielny Zakład Opieki Zdrowotnej z siedzibą w Łęcznej
Łęczna, Poland · Recruiting
Unidade de Queimados do CHUC
Coimbra, Portugal · Recruiting
Hospital Universitario Vall d'Hebron
Barcelona, Spain · Recruiting
Hospital Universitario La Paz Edificio Traumatología
Madrid, Spain · Recruiting
Hospital Universitatrio y Politécnico La Fe
Valencia, Spain · Recruiting
Universtitätsspital Zürich
Zurich, Switzerland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.